Genetic engineering ofFrancisella tularensisLVS for use as a novel live vaccine platform againstPseudomonas aeruginosainfections-Reference-Cited by-同舟云学术

Genetic engineering ofFrancisella tularensisLVS for use as a novel live vaccine platform againstPseudomonas aeruginosainfections

Published:2015-01-23 Issue:2 Volume:6 Page:82-88
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Robinson Cory M,Kobe Brianna N,Schmitt Deanna M,Phair Brian,Gilson Tricia,Jung Joo-Yong,Roberts Lawton,Liao Jialin,Camerlengo Chelsea,Chang Brandon,Davis Mackenzie,Figurski Leah,Sindeldecker Devin,Horzempa Joseph

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

http://www.tandfonline.com/doi/pdf/10.1080/21655979.2015.1011033

Reference34 articles.

1. Tularemia

2. Vaccines Against Francisella Tularensis

3. Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans

4. Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis

5. Recent developments for Pseudomonas vaccines

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of an N-terminal tag (580N) that improves the biosynthesis of fluorescent proteins in Francisella tularensis and other Gram-negative bacteria;Molecular and Cellular Probes;2024-04

2. PdpC, a secreted effector protein of the type six secretion system, is required for erythrocyte invasion by Francisella tularensis LVS;Frontiers in Cellular and Infection Microbiology;2022-09-27

3. Verification and application of a modified carbapenem inactivation method (mCIM) on Pseudomonas aeruginosa: a potential screening methodology on carbapenemases phenotype in Bacillus cereus;Bioengineered;2022-05-02

4. Role of dipA and pilD in Francisella tularensis Susceptibility to Resazurin;Antibiotics;2021-08-17

5. Understanding Pseudomonas aeruginosa–Host Interactions: The Ongoing Quest for an Efficacious Vaccine;Cells;2020-12-05